Takeda Pharmaceutical is a global, research and development-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines. Takeda Pharmaceutical focuses its R&D efforts on oncology, gastroenterology and central nervous system therapeutic areas plus vaccines. Takeda Pharmaceutical conducts R&D both internally and with partners to stay at the leading edge of innovation. New innovative products, especially in oncology and gastroenterology, as well as their presence in Emerging Markets, fuel the growth of Takeda Pharmaceutical. More than 30,000 Takeda Pharmaceutical employees are committed to improving quality of life for patients, working with their partners in health care in more than 70 countries.
Through Takeda Pharmaceutcal’s partnership with Shot@Life, they are helping to expand access to lifesaving measles vaccines to children in approximately 40 countries in Africa, Asia and Latin America, many living in hard-to-reach locations. Takeda’s support will help vaccinate millions of children by 2026.
Takeda Pharmaceutical also supports health system strengthening efforts in 14 African countries. Since 2020, Takeda has partnered with Shot@Life to enhance disease surveillance systems, support vaccination efforts, and advocate for global immunizations through a commitment of 550 million Japanese yen (more than $5 million USD).